Under HDS conditions, cancer cells exhibit the capacity to adapt their growth signaling and metabolic states, potentially involving upregulation of the wingless/Wnt pathway and mTOR signaling, along with evasion of apoptosis and genome instability, which contributes to elevated mutation rates [6–9]. This evidence concerns the gene MTOR and cancer.